We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVVE
11076
PUT
DELISTED
Nuvve Holding Corp
NVVE
0
RCON icon
11077
Recon Technology
RCON
$2.32M
$124K ﹤0.01%
10,381
+4,853
+88% +$73.2K
RXRX icon
11078
PUT
Recursion Pharmaceuticals
RXRX
$1.69B
$124K ﹤0.01%
+15,200
New +$102K
YEXT icon
11079
CALL
Yext
YEXT
$594M
$124K ﹤0.01%
25,900
+9,000
+53% +$50K
ZDGE icon
11080
PUT
Zedge
ZDGE
$38.4M
$124K ﹤0.01%
43,100
-62,200
-59% -$307K
SCTL
11081
CALL
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$124K ﹤0.01%
156,200
-38,100
-20% -$40.9K
ATRA icon
11082
CALL
Atara Biotherapeutics
ATRA
$81.2M
$123K ﹤0.01%
632
-220
-26% -$35.9K
BITQ icon
11083
PUT
Bitwise Crypto Industry Innovators ETF
BITQ
$381M
$123K ﹤0.01%
22,200
+5,000
+29% +$50.4K
FULC icon
11084
PUT
Fulcrum Therapeutics
FULC
$285M
$123K ﹤0.01%
25,200
-5,400
-18% -$52.8K
KOD icon
11085
PUT
Kodiak Sciences
KOD
$2.6B
$123K ﹤0.01%
16,100
-104,100
-87% -$731K
LTRX icon
11086
PUT
Lantronix
LTRX
$289M
$123K ﹤0.01%
+22,800
New +$132K
MTW icon
11087
PUT
Manitowoc
MTW
$746M
$123K ﹤0.01%
11,700
-2,400
-17% -$30.1K
LOTZ
11088
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
$123K ﹤0.01%
310,755
+230,549
+287% +$171K
CODX
11089
PUT
Co-Diagnostics
CODX
$9.77M
$122K ﹤0.01%
727
-963
-57% -$146K
COOK icon
11090
PUT
Traeger
COOK
$164M
$122K ﹤0.01%
574
-686
-54% -$191K
MPX
11091
DELISTED
Marine Products Corp
MPX
$122K ﹤0.01%
+12,840
New +$142K
PYPD icon
11092
PolyPid
PYPD
$90.9M
$122K ﹤0.01%
876
-267
-23% -$40K
VRT icon
11093
CALL
Vertiv
VRT
$113B
$122K ﹤0.01%
14,900
-30,100
-67% -$341K
VAPO
11094
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$122K ﹤0.01%
6,029
+2,885
+92% +$106K
SURF
11095
CALL
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$122K ﹤0.01%
74,200
+14,700
+25% +$30.5K
BLU
11096
PUT
DELISTED
BELLUS Health Inc.
BLU
$122K ﹤0.01%
13,200
-28,900
-69% -$236K
IPAXU
11097
DELISTED
Inflection Point Acquisition Corp. Units
IPAXU
$122K ﹤0.01%
12,434
-2,303
-16% -$22.7K
CRU
11098
CALL
DELISTED
Crucible Acquisition Corporation
CRU
$122K ﹤0.01%
12,400
-35,000
-74% -$344K
PZN
11099
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$122K ﹤0.01%
18,631
-36,051
-66% -$245K
CTIC
11100
PUT
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$122K ﹤0.01%
20,400
+2,700
+15% +$13.8K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.